Company Description
SBC Medical Group Holdings Incorporated provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and internationally.
The company offers advertising and marketing services; staff management services, such as recruitment and training; booking reservations for franchisee clinic customers; assistance with franchisee employee housing rentals and facility rentals; construction and design of franchisee clinics; medical equipment; and medical consumables procurement.
It provides IT software solutions; breast augmentation, liposuction, and rejuvenation treatments, including treatment of wrinkles, acne, scars, cellulite, excess fat, discoloration, and signs of aging; laser skin toning and spot removal; eyes double fold surgery; rhinoplasty; treatment of osmidrosis and hyperhidrosis; hair transplants; gynecological formation treatments; laser hair removal; face line surgeries; cosmetical dental procedures; tattoo removal; lasik eye surgery; lateral canthoplasty; brow lift procedures; androgenetic alopecia treatment; and cheek sagging prevention methods.
The company was founded in 2000 and is headquartered in Irvine, California.
| Country | United States |
| Founded | 2000 |
| Industry | Consulting Services |
| Sector | Industrials |
| Employees | 1,639 |
| CEO | Yoshiyuki Aikawa |
Contact Details
Address: 200 Spectrum Center Drive, Suite 300 Irvine, California 92618 United States | |
| Phone | 949-593-0250 |
| Website | sbc-holdings.com |
Stock Details
| Ticker Symbol | SBC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001930313 |
| ISIN Number | US73245B1070 |
| Employer ID | 88-1263511 |
| SIC Code | 8011 |
Key Executives
| Name | Position |
|---|---|
| Dr. Yoshiyuki Aikawa | Chairman and Chief Executive Officer |
| Ryoji Murata | Chief Financial Officer |
| Yuji Katayose | Marketing Director |
| Akira Komatsu | Chief Strategy Officer and Secretary |
| Yoshimune Tanaka | Property Acquisition Director |
| Yuya Yoshida | Chief Operating Officer and Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 20, 2024 | 8-K | Current Report |
| Nov 14, 2024 | 424B3 | Prospectus |
| Nov 13, 2024 | 10-Q | Quarterly Report |
| Nov 13, 2024 | 8-K | Current Report |
| Oct 21, 2024 | 424B3 | Prospectus |
| Oct 18, 2024 | EFFECT | Notice of Effectiveness |
| Oct 15, 2024 | UPLOAD | Filing |
| Oct 8, 2024 | S-1 | General form for registration of securities under the Securities Act of 1933 |
| Oct 1, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
| Sep 24, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |